Skip to main content
. 2021 Aug 7;9(2):347–364. doi: 10.1007/s40487-021-00167-z

Fig. 2.

Fig. 2

NOVA study design. CR complete response, PR partial response, PFS progression-free survival, RECIST Response Evaluation Criteria in Solid Tumours, gBRCAmut = germline BRCA mutation, non-gBRCAmut = No germline BRCA mutation